Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Anna DeFilippis

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancer Discovery|December 12, 2012
Hello out there...is anybody listening?Rosa Anna DeFilippis, Thea D Tlsty
Journal of Virology|March 30, 2004
Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cellsStacy M Horner, Rosa Anna DeFilippis, Laertes Manuelidis, et al.
Journal of Virology|December 28, 2002
Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cellsRosa Anna DeFilippis, Edward C Goodwin, Lingling Wu, et al.
Bioinformatics (Oxford, England)|August 16, 2008
Graphical methods for quantifying macromolecules through bright field imagingHang Chang, Rosa Anna DeFilippis, Thea D Tlsty, et al.
Bioorganic Chemistry|February 11, 2026
An unprecedented potent inhibitor of MV4-11 cells: investigations into the mechanism of action beyond FLT3 inhibitionXiuqi Wang, Rosa Anna DeFilippis, Huimin Geng, et al.
Journal of Medicinal Chemistry|June 5, 2024
Overcoming Secondary Mutations of Type II Kinase InhibitorsXiuqi Wang, Rosa Anna DeFilippis, Wei Yan, et al.
Bioorganic Chemistry|November 23, 2023
N-(3-Methoxyphenyl)-6-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl)pyridin-2-amine is an inhibitor of the FLT3-ITD and BCR-ABL pathways, and potently inhibits FLT3-ITD/D835Y and FLT3-ITD/F691L secondary mutantsXiuqi Wang, Rosa Anna DeFilippis, Yuet-Kin Leung, et al.
Cancer Research|May 6, 2004
Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cellsAmanda Psyrri, Rosa Anna DeFilippis, Anne P B Edwards, et al.
European Journal of Medicinal Chemistry|December 6, 2023
An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691LXiuqi Wang, Rosa Anna DeFilippis, Tsigereda Weldemichael, et al.
Cancer Research|August 31, 2014
Stress signaling from human mammary epithelial cells contributes to phenotypes of mammographic densityRosa Anna DeFilippis, Colleen Fordyce, Kelley Patten, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancer Discovery|December 12, 2012
Hello out there...is anybody listening?Rosa Anna DeFilippis, Thea D Tlsty
Journal of Virology|March 30, 2004
Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cellsStacy M Horner, Rosa Anna DeFilippis, Laertes Manuelidis, et al.
Journal of Virology|December 28, 2002
Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cellsRosa Anna DeFilippis, Edward C Goodwin, Lingling Wu, et al.
Bioinformatics (Oxford, England)|August 16, 2008
Graphical methods for quantifying macromolecules through bright field imagingHang Chang, Rosa Anna DeFilippis, Thea D Tlsty, et al.
Bioorganic Chemistry|February 11, 2026
An unprecedented potent inhibitor of MV4-11 cells: investigations into the mechanism of action beyond FLT3 inhibitionXiuqi Wang, Rosa Anna DeFilippis, Huimin Geng, et al.
Journal of Medicinal Chemistry|June 5, 2024
Overcoming Secondary Mutations of Type II Kinase InhibitorsXiuqi Wang, Rosa Anna DeFilippis, Wei Yan, et al.
Bioorganic Chemistry|November 23, 2023
N-(3-Methoxyphenyl)-6-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl)pyridin-2-amine is an inhibitor of the FLT3-ITD and BCR-ABL pathways, and potently inhibits FLT3-ITD/D835Y and FLT3-ITD/F691L secondary mutantsXiuqi Wang, Rosa Anna DeFilippis, Yuet-Kin Leung, et al.
Cancer Research|May 6, 2004
Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cellsAmanda Psyrri, Rosa Anna DeFilippis, Anne P B Edwards, et al.
European Journal of Medicinal Chemistry|December 6, 2023
An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691LXiuqi Wang, Rosa Anna DeFilippis, Tsigereda Weldemichael, et al.
Cancer Research|August 31, 2014
Stress signaling from human mammary epithelial cells contributes to phenotypes of mammographic densityRosa Anna DeFilippis, Colleen Fordyce, Kelley Patten, et al.
Pageof 2